FDA Clearance Tracker · P230021-S003
Duo Venous Stent System
Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 12, 2026
Approved
Time to decision
139 days
Received Sep 26, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230021-S003
- Device name
- Duo Venous Stent System
- Applicant location
- Plymouth, MN
- Received
- Sep 26, 2025
- Decided
- Feb 12, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P230021
Device type
- Device type
- Stent, iliac vein (QAN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the updated Instruction for Use for both the Duo Venous Stent System (Pin/Pull delivery system) and Duo Venous Stent System (Triaxial Handle delivery system) with final results of the VIVID study.
Source documents
Other decisions for Philips Image Guided Therapy Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- IntraSight Plus510(k)
K253714 · Decided Feb 24, 2026 · 92 days after receipt
Device type: System, Imaging, Pulsed Echo, Ultrasonic (IYO) · Radiology & Imaging
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.